Publication | Closed Access

Polyoxometalate–biomolecule conjugates: A new approach to create hybrid drugs for cancer therapeutics

Drug TargetingPolyoxometalate–biomolecule ConjugatesPolymer-drug ConjugateHybrid DrugsDrug DiscoveryMedicineBioconjugationTumor TargetingChemodynamic TherapyAnti-cancer AgentRadiation OncologyPharmacologyCancer TherapeuticsBiomolecular EngineeringHealth Sciences